Horizon Pharma (HZNP) Reports In-Line Q1 EPS; Lifts FY15 Revenue Outlook

Horizon Pharma (NASDAQ: HZNP) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $113.1 million versus the consensus estimate of $104.2 million.

Horizon Pharma sees FY2015 revenue of $590-610 million, versus prior guidance of $450-475 million and the consensus of $538.8 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c